Table 4.
Group |
P Value |
|||||
---|---|---|---|---|---|---|
Gene | SC | FF | HF | SC vs. FF | FF vs. HF | SC vs. HF |
Fibrosis | ||||||
TGFβ1 | 2.81 ± 0.20 | 13.42 ± 1.46 | 4.79 ± 0.18 | 0.01 | 0.0009 | 0.123 |
ASMA | 8.74 ± 3.63 | 35.12 ± 10.39 | 16.59 ± 9.22 | 0.017 | 0.16 | 0.38 |
Collagen type 1α1 | 0.20 ± 0.05 | 3.41 ± 0.63 | 0.69 ± 0.09 | 0.013 | 0.014 | 0.14 |
Lumican | 6.33 ± 0.68 | 60.47 ± 5.38 | 10.63 ± 0.57 | 0.001 | 0.013 | 0.11 |
TIMP1 | 0.06 ± 0.01 | 1.97 ± 0.01 | 0.18 ± 0.03 | 0.0002 | 0.0002 | 0.21 |
HGF | 1.27 ± 0.13 | 2.52 ± 0.10 | 1.47 ± 0.05 | 0.017 | 0.0066 | 0.61 |
Sp1 | 3.55 ± 0.75 | 4.52 ± 0.55 | 3.61 ± 0.16 | 0.27 | 0.045 | 0.93 |
Inflammation | ||||||
TNFα | 0.02 ± 0.003 | 0.20 ± 0.012 | 0.04 ± 0.004 | 0.0001 | 0.0001 | 0.18 |
Osteopontin | 5.83 ± 1.66 | 32.16 ± 9.26 | 5.41 ± 1.00 | 0.0017 | 0.0013 | 0.82 |
Fatty Acid trafficking | ||||||
FABP | 6.95 ± 1.20 | 4.31 ± 0.69 | 9.52 ± 0.77 | 0.096 | 0.0001 | 0.075 |
Cellular stress | ||||||
SOD1 | 1.69 ± 0.27 | 1.17 ± 0.11 | 1.73 ± 0.12 | 0.14 | 0.0032 | 0.89 |
CHOP | 1.15 ± 0.53 | 2.86 ± 0.16 | 1.06 ± 0.06 | 0.0023 | 0.0014 | 0.72 |
PERK | 33.05 ± 0.20 | 7.04 ± 0.32 | 3.43 ± 0.10 | 0.0015 | 0.0008 | 0.57 |
BBC3/PUMA | 4.05 ± 1.47 | 3.68 ± 0.24 | 2.87 ± 0.27 | 0.67 | 0.44 | 0.22 |
ATF6 | 3.98 ± 0.81 | 5.09 ± 0.49 | 3.70 ± 0.29 | 0.28 | 0.025 | 0.75 |
BiP/GRP78 | 1.38 ± 0.38 | 1.54 ± 0.19 | 1.48 ± 0.15 | 0.73 | 0.81 | 0.81 |
TGFβ1, transforming growth factor-β1; ASMA, anti-smooth muscle actin; TIMP1, tissue inhibitor of metalloproteinase; HGF, hepatocyte growth factor; Sp1, specificity protein 1; FABP, fatty acid-binding protein; CHOP, CCAAT enhancer-binding protein homologous protein; PERK, eukaryotic translation initiation factor 2α kinase 3; PUMA, Bcl-2 binding component 3; ATF6, activating transcription factor 6.